Pancreatic Enzyme Replacement Therapy: Drugs
Commons · Question 68110 · Tabled 15 Jul 2025 · Department of Health and Social Care · Official record
Answered 22 Jul 2025
Question
Asked by Josh Babarinde
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the supply of Pancreatin for people struggling to acquire their required quantity and dosage.
Answer
Answered by Karin Smyth, 22 Jul 2025
The Department is currently managing a supply issue with the pancreatic enzyme replacement therapy (PERT) Creon, which is used by patients with conditions such as cystic fibrosis and certain cancers, including pancreatic cancer and neuroendocrine cancer. ...